CtDNA and CTCs in Liquid Biopsy - Current Status and Where We Need to Progress

Overview

Journal Comput Struct Biotechnol J

Specialty Biotechnology

Date 2018 Jul 7

PMID 29977481

Citations 108

Authors

Martin H D Neumann

Sebastian Bender

Thomas Krahn

Thomas Schlange

Affiliations

Soon will be listed here.

Abstract

We discuss the current status of liquid biopsy and its advantages and challenges with a focus on pre-analytical sample handling, technologies and workflows. The potential of circulating tumor cells and circulating tumor DNA is pointed out and an overview of corresponding technologies is given.

Citing Articles

Recent progress in prompt molecular detection of liquid biopsy using Cas enzymes: innovative approaches for cancer diagnosis and analysis.

Yazdi Z, Roshannezhad S, Sharif S, Abbaszadegan M J Transl Med. 2024; 22(1):1173.

PMID: 39741289 PMC: 11686959. DOI: 10.1186/s12967-024-05908-y.

Definite Treatment Delay With Neoadjuvant Chemotherapy and Longitudinal Monitoring by Circulating Tumor DNA for Advanced Cervical Cancer During Pregnancy: A Case Series and Literature Review.

Zhang X, Yu H, Chen K, Ding B, Shen Y Cancer Rep (Hoboken). 2024; 7(11):e70021.

PMID: 39506833 PMC: 11541060. DOI: 10.1002/cnr2.70021.

Tumor-Derived Extracellular Vesicles as Liquid Biopsy for Diagnosis and Prognosis of Solid Tumors: Their Clinical Utility and Reliability as Tumor Biomarkers.

Dabral P, Bhasin N, Ranjan M, Makhlouf M, Abd Elmageed Z Cancers (Basel). 2024; 16(13).

PMID: 39001524 PMC: 11240796. DOI: 10.3390/cancers16132462.

Detection and Characterization of Methylated Circulating Tumor DNA in Gastric Cancer.

Seo S, Youn S, Bae J, Lee S, Lee S Int J Mol Sci. 2024; 25(13).

PMID: 39000483 PMC: 11242052. DOI: 10.3390/ijms25137377.

Liquid biopsy for non-invasive monitoring of patients with kidney transplants.

Nassar A, Cashman K, Rao S, Dagher M, OBrien C, Afif J Front Transplant. 2024; 2:1148725.

PMID: 38993899 PMC: 11235308. DOI: 10.3389/frtra.2023.1148725.

References

Vona G, Sabile A, Louha M, Sitruk V, Romana S, Schutze K . Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol. 2000; 156(1):57-63. PMC: 1868645. DOI: 10.1016/S0002-9440(10)64706-2. View

Stroun M, Maurice P, Vasioukhin V, Lyautey J, LEDERREY C, Lefort F . The origin and mechanism of circulating DNA. Ann N Y Acad Sci. 2000; 906:161-8. DOI: 10.1111/j.1749-6632.2000.tb06608.x. View

Cristofanilli M, Budd G, Ellis M, Stopeck A, Matera J, Miller M . Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004; 351(8):781-91. DOI: 10.1056/NEJMoa040766. View

de Bono J, Scher H, Montgomery R, Parker C, Miller M, Tissing H . Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res. 2008; 14(19):6302-9. DOI: 10.1158/1078-0432.CCR-08-0872. View

Nguyen D, Bos P, Massague J . Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009; 9(4):274-84. DOI: 10.1038/nrc2622. View

Plebani M . The detection and prevention of errors in laboratory medicine. Ann Clin Biochem. 2009; 47(Pt 2):101-10. DOI: 10.1258/acb.2009.009222. View

Farace F, Massard C, Vimond N, Drusch F, Jacques N, Billiot F . A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas. Br J Cancer. 2011; 105(6):847-53. PMC: 3171010. DOI: 10.1038/bjc.2011.294. View

Mouliere F, Robert B, Peyrotte E, Del Rio M, Ychou M, Molina F . High fragmentation characterizes tumour-derived circulating DNA. PLoS One. 2011; 6(9):e23418. PMC: 3167805. DOI: 10.1371/journal.pone.0023418. View

Shaw J, Page K, Blighe K, Hava N, Guttery D, Ward B . Genomic analysis of circulating cell-free DNA infers breast cancer dormancy. Genome Res. 2011; 22(2):220-31. PMC: 3266030. DOI: 10.1101/gr.123497.111. View

10.

Krebs M, Hou J, Sloane R, Lancashire L, Priest L, Nonaka D . Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. J Thorac Oncol. 2011; 7(2):306-15. DOI: 10.1097/JTO.0b013e31823c5c16. View

11.

Hawkins R . Managing the pre- and post-analytical phases of the total testing process. Ann Lab Med. 2012; 32(1):5-16. PMC: 3255486. DOI: 10.3343/alm.2012.32.1.5. View

12.

Gerlinger M, Rowan A, Horswell S, Math M, Larkin J, Endesfelder D . Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012; 366(10):883-892. PMC: 4878653. DOI: 10.1056/NEJMoa1113205. View

13.

Alix-Panabieres C, Pantel K . Circulating tumor cells: liquid biopsy of cancer. Clin Chem. 2012; 59(1):110-8. DOI: 10.1373/clinchem.2012.194258. View

14.

Fabbri F, Carloni S, Zoli W, Ulivi P, Gallerani G, Fici P . Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs. Cancer Lett. 2013; 335(1):225-31. DOI: 10.1016/j.canlet.2013.02.015. View

15.

Ozkumur E, Shah A, Ciciliano J, Emmink B, Miyamoto D, Brachtel E . Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci Transl Med. 2013; 5(179):179ra47. PMC: 3760275. DOI: 10.1126/scitranslmed.3005616. View

16.

Murtaza M, Dawson S, Tsui D, Gale D, Forshew T, Piskorz A . Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature. 2013; 497(7447):108-12. DOI: 10.1038/nature12065. View

17.

Coumans F, van Dalum G, Beck M, Terstappen L . Filter characteristics influencing circulating tumor cell enrichment from whole blood. PLoS One. 2013; 8(4):e61770. PMC: 3634026. DOI: 10.1371/journal.pone.0061770. View

18.

Green S . The cost of poor blood specimen quality and errors in preanalytical processes. Clin Biochem. 2013; 46(13-14):1175-9. DOI: 10.1016/j.clinbiochem.2013.06.001. View

19.

Bedard P, Hansen A, Ratain M, Siu L . Tumour heterogeneity in the clinic. Nature. 2013; 501(7467):355-64. PMC: 5224525. DOI: 10.1038/nature12627. View

20.

Sollier E, Go D, Che J, Gossett D, OByrne S, Weaver W . Size-selective collection of circulating tumor cells using Vortex technology. Lab Chip. 2013; 14(1):63-77. DOI: 10.1039/c3lc50689d. View